It has also been well documented that the inhibition of HO-1 is capable of restoring the chemosensitivity of resistant cells in multiple cancer types, including ovarian cancer [169], acute myeloid leukemia [170], and melanoma [154]. The gene discussed is HMOX1; the disease is cancer.